These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24267770)
1. [Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation]. Neino Mourtala Mohamed A; Tummino C; Gouitaa M; Chanez P Rev Mal Respir; 2013 Nov; 30(9):785-8. PubMed ID: 24267770 [TBL] [Abstract][Full Text] [Related]
2. [Regarding a case of rifampicin-induced pruritus and thrombocytopenia]. Ponvert C Rev Mal Respir; 2014 Jan; 31(1):84. PubMed ID: 24461449 [No Abstract] [Full Text] [Related]
5. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related]
6. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
7. A case of thrombocytopenia caused by rifampicin and pyrazinamide. Bansal R; Sharma PK; Sharma A Indian J Pharmacol; 2013; 45(4):405-7. PubMed ID: 24014922 [TBL] [Abstract][Full Text] [Related]
8. [A case of pulmonary tuberculosis complicated with severe thrombocytopenia during treatment]. Hashiguchi N; Furuyama K; Kim M; Hirose N Kekkaku; 2012 Apr; 87(4):345-9. PubMed ID: 22702083 [TBL] [Abstract][Full Text] [Related]
9. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case]. Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284 [No Abstract] [Full Text] [Related]
10. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations. Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981 [TBL] [Abstract][Full Text] [Related]
12. [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin]. Kuroda F; Yagi T; Yamagishi F; Mizutani F; Sasaki Y; Wada A Kekkaku; 1999 Nov; 74(11):803-7. PubMed ID: 10599213 [TBL] [Abstract][Full Text] [Related]
13. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus. Martínez E; Collazos J; Mayo J Clin Infect Dis; 1998 Nov; 27(5):1329-30. PubMed ID: 9827298 [No Abstract] [Full Text] [Related]
14. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers. Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999 [TBL] [Abstract][Full Text] [Related]
15. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
16. A case of acute and severe thrombocytopenia due to readministration of rifampicin. Mori M; Izawa K; Fujikawa T; Uenami T; Sugano T; Kagami S; Namba Y; Yano Y; Yoneda T; Kitada S; Kimura H; Yamaguchi T; Yokota S; Maekura R J Infect Chemother; 2011 Apr; 17(2):288-90. PubMed ID: 20827562 [TBL] [Abstract][Full Text] [Related]
17. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach. Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R; Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298 [TBL] [Abstract][Full Text] [Related]
18. [A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration]. Shinoda C; Hayashi R; Kawasaki A; Maruyama M; Kobayashi M Nihon Kokyuki Gakkai Zasshi; 2001 Dec; 39(12):955-60. PubMed ID: 11875815 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy]. Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424 [No Abstract] [Full Text] [Related] [Next] [New Search]